See more : U.S. Gold Corp. (USAU) Income Statement Analysis – Financial Results
Complete financial analysis of McKesson Europe AG (CAKFY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of McKesson Europe AG, a leading company in the Medical – Distribution industry within the Healthcare sector.
- Jinhui Shipping and Transportation Limited (JIN.OL) Income Statement Analysis – Financial Results
- AroCell AB (publ) (AROC.ST) Income Statement Analysis – Financial Results
- Tsubaki Nakashima Co., Ltd. (6464.T) Income Statement Analysis – Financial Results
- noco-noco Inc. (NCNC) Income Statement Analysis – Financial Results
- SPO Networks, Inc. (SPOI) Income Statement Analysis – Financial Results
McKesson Europe AG (CAKFY)
About McKesson Europe AG
McKesson Europe AG provides logistics and other services to the pharmaceutical and healthcare sectors worldwide. The company operates through two divisions, Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution division engages in the wholesale of pharmaceutical and other health care products. This division serves its customers through 90 wholesale branches that supply pharmaceutical products to approximately 40,000 pharmacies and hospitals, as well as operates 70 distribution centers in Europe. The Retail Pharmacy division operates approximately 2,000 owned pharmacies and approximately 8,000 members in its brand partnership program. This division also provides outpatient drug, e-commerce, and home care services primarily in Belgium, Ireland, Italy, and the United Kingdom under the Lloyds Pharmacy brand. In addition, this division provides traditional prescription drugs, over-the-counter products, and medical services. It also provides other services for pharmacists, such as the organization and management of pharmacy cooperation programs in the Great Britain, France, Portugal, and Belgium. The company was formerly known as Celesio AG and changed its name to McKesson Europe AG in September 2017. The company was founded in 1835 and is headquartered in Stuttgart, Germany. McKesson Europe AG is a subsidiary of McKesson Corporation.
Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 9.26B | 16.75B | 17.12B | 21.18B | 21.09B | 20.64B | 21.41B | 22.33B | 21.41B | 22.27B | 23.03B | 23.28B | 21.50B | 21.83B | 22.35B | 21.57B | 20.49B | 19.15B | 18.54B | 18.38B |
Cost of Revenue | 8.45B | 14.93B | 15.23B | 19.13B | 18.96B | 18.51B | 19.07B | 19.94B | 19.06B | 19.84B | 20.28B | 20.44B | 18.99B | 19.42B | 19.83B | -19.14B | -18.26B | -17.10B | 16.67B | 16.54B |
Gross Profit | 803.80M | 1.82B | 1.88B | 2.05B | 2.13B | 2.13B | 2.35B | 2.38B | 2.35B | 2.43B | 2.75B | 2.84B | 2.51B | 2.41B | 2.52B | 40.71B | 38.75B | 36.25B | 1.87B | 1.84B |
Gross Profit Ratio | 8.68% | 10.84% | 11.00% | 9.66% | 10.08% | 10.32% | 10.97% | 10.67% | 10.98% | 10.90% | 11.94% | 12.19% | 11.66% | 11.04% | 11.29% | 188.73% | 189.09% | 189.26% | 10.07% | 10.02% |
Research & Development | 2.20M | 0.00 | 4.20M | 0.00 | 0.00 | 5.10M | 6.90M | 7.10M | 7.00M | 7.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 21.70M | 30.80M | 39.30M | 39.20M | 41.20M | 45.90M | 41.40M | 45.10M | 41.50M | 48.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 46.30M | 42.60M | 0.00 | 46.40M | 41.70M | 55.80M | 59.60M | 54.80M | 48.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -49.52M | -43.28M | -42.23M | 0.00 | 0.00 |
SG&A | 21.70M | 77.10M | 81.90M | 39.20M | 87.60M | 87.60M | 97.20M | 104.70M | 96.30M | 96.60M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -49.52M | -43.28M | -42.23M | 0.00 | 0.00 |
Other Expenses | 749.20M | 1.65B | 1.71B | 1.98B | 2.02B | 1.78B | 1.88B | 1.94B | 1.89B | 1.97B | 2.38B | 2.27B | 2.00B | 425.65M | 1.80B | 0.00 | 0.00 | 0.00 | 600.83M | 599.80M |
Operating Expenses | 773.10M | 1.72B | 1.80B | 2.02B | 2.11B | 1.88B | 1.99B | 2.05B | 1.99B | 2.07B | 2.38B | 2.27B | 2.00B | 425.65M | 1.80B | -49.52M | -43.28M | -42.23M | 600.83M | 599.80M |
Cost & Expenses | 9.23B | 16.66B | 17.03B | 21.15B | 21.08B | 20.39B | 21.05B | 21.99B | 21.04B | 21.91B | 22.66B | 22.71B | 20.99B | 19.85B | 21.62B | 2.38B | 2.19B | 2.01B | 17.27B | 17.14B |
Interest Income | 2.10M | 800.00K | 3.10M | 7.00M | 4.80M | 8.60M | 5.10M | 7.80M | 9.80M | 10.60M | 8.60M | 12.20M | 12.80M | 17.23M | 14.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 15.50M | 27.00M | 47.30M | 45.40M | 52.00M | 73.00M | 61.20M | 96.80M | 144.90M | 178.00M | 157.30M | 150.50M | 129.90M | 145.77M | 139.74M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 284.60M | 302.50M | 151.80M | 432.10M | 1.09B | 111.30M | 111.30M | 250.40M | 126.20M | 172.40M | 143.40M | 133.00M | 115.70M | 401.03M | 109.69M | 117.91M | 97.62M | 93.23M | 99.88M | 104.70M |
EBITDA | 218.70M | 416.70M | 421.00M | 182.50M | 180.20M | 255.00M | 647.90M | 501.70M | 528.50M | 299.40M | 404.70M | 692.80M | 360.90M | 672.01M | 858.24M | 541.08M | 518.40M | 429.17M | 473.68M | 448.33M |
EBITDA Ratio | 2.36% | 2.49% | 2.46% | 0.86% | 0.85% | 1.24% | 3.03% | 2.25% | 2.47% | 1.34% | 1.76% | 2.98% | 1.68% | 3.08% | 3.84% | 2.51% | 2.53% | 2.24% | 2.55% | 2.44% |
Operating Income | 58.90M | 132.10M | 118.50M | 23.50M | -284.60M | -699.40M | 621.50M | 158.80M | 406.60M | 370.10M | 236.80M | 565.60M | 237.60M | 256.22M | 727.75M | 685.80M | 648.15M | 590.28M | 455.77M | 435.59M |
Operating Income Ratio | 0.64% | 0.79% | 0.69% | 0.11% | -1.35% | -3.39% | 2.90% | 0.71% | 1.90% | 1.66% | 1.03% | 2.43% | 1.11% | 1.17% | 3.26% | 3.18% | 3.16% | 3.08% | 2.46% | 2.37% |
Total Other Income/Expenses | -94.00M | -104.30M | -148.00M | -31.20M | -19.50M | -49.50M | -47.90M | 0.00 | -137.90M | -155.40M | -132.80M | -156.30M | -122.30M | -131.01M | -118.94M | 0.00 | 0.00 | 0.00 | -81.97M | -91.96M |
Income Before Tax | -35.10M | 27.80M | -29.50M | -7.70M | -304.10M | -748.90M | 573.60M | 158.80M | 268.70M | 214.70M | 104.00M | 409.30M | 115.30M | 125.21M | 608.81M | 0.00 | 0.00 | 0.00 | 373.80M | 343.63M |
Income Before Tax Ratio | -0.38% | 0.17% | -0.17% | -0.04% | -1.44% | -3.63% | 2.68% | 0.71% | 1.26% | 0.96% | 0.45% | 1.76% | 0.54% | 0.57% | 2.72% | 0.00% | 0.00% | 0.00% | 2.02% | 1.87% |
Income Tax Expense | 14.30M | 26.90M | 36.60M | 44.30M | -4.90M | 55.60M | 82.50M | 105.90M | 97.50M | 105.10M | 97.90M | 144.30M | 113.00M | 143.74M | 173.40M | 0.00 | 0.00 | 0.00 | 119.83M | 104.07M |
Net Income | -49.40M | 900.00K | -66.10M | -59.00M | -299.00M | -966.90M | 392.90M | 48.60M | 159.90M | -156.10M | 6.10M | 265.00M | 2.30M | -18.53M | 435.42M | 423.17M | 420.78M | 335.94M | 253.97M | 239.56M |
Net Income Ratio | -0.53% | 0.01% | -0.39% | -0.28% | -1.42% | -4.68% | 1.83% | 0.22% | 0.75% | -0.70% | 0.03% | 1.14% | 0.01% | -0.08% | 1.95% | 1.96% | 2.05% | 1.75% | 1.37% | 1.30% |
EPS | -0.05 | 0.00 | -0.07 | -0.06 | -0.29 | -0.95 | 0.39 | 0.05 | 0.19 | -0.18 | 0.01 | 0.31 | 0.00 | -0.02 | 0.51 | 0.50 | 0.49 | 0.39 | 0.30 | 0.28 |
EPS Diluted | -0.05 | 0.00 | -0.07 | -0.06 | -0.29 | -0.95 | 0.39 | 0.05 | 0.17 | -0.18 | 0.01 | 0.29 | 0.00 | -0.02 | 0.51 | 0.50 | 0.49 | 0.39 | 0.30 | 0.28 |
Weighted Avg Shares Out | 1.02B | 1.02B | 1.02B | 1.02B | 1.02B | 1.02B | 1.02B | 995.21M | 850.50M | 850.50M | 850.50M | 850.50M | 850.50M | 850.50M | 850.50M | 850.50M | 851.00M | 851.00M | 851.00M | 851.00M |
Weighted Avg Shares Out (Dil) | 1.02B | 1.02B | 1.02B | 1.02B | 1.02B | 1.02B | 1.02B | 995.21M | 928.35M | 850.50M | 850.50M | 928.31M | 850.50M | 850.50M | 850.50M | 850.50M | 851.00M | 851.00M | 851.00M | 851.00M |
Source: https://incomestatements.info
Category: Stock Reports